The first testing kit granted market approval in China developed by a medical testing solutions provider based in Shanghai, which can screen people for both the novel coronavirus and the influenza virus is also being prepared for entry to overseas markets.

The Shanghai Science and Technology Commission said recently that the testing kit, which can screen individuals for the two viruses at once and distinguish between them, was granted market approval by the National Medical Products Administration on Aug 16.

In China and the United States, where COVID-19 testing kits are subject to strict medical product approval, the new kit was the first of its kind to be based on a fluorescence quantitative polymerase chain reaction platform.

Experts said patients suffering from novel coronavirus pneumonia and influenza may show similar clinical symptoms, such as fever, sore throat, cough and fatigue, and even CT scan images of their lungs may look similar.

The availability of such a combined testing kit will help doctors determine why a patient is running a fever and choose the best medical treatment plan as soon as possible. It will also help doctors and medical institutions respond swiftly to avoid the spread of COVID-19.

According to this medical testing solutions provider, their testing kit is sensitive to all COVID-19 virus variants so far, including the highly transmissible Delta variant.

For further information about China’s imports & exports of medical supplies. Please CONTACT US.